Blake E. Max
Clinical Associate Professor, Pharmacy Practice
Contact
Office Phone:
Email:
Related Sites:
About
Teaching and Supervision
Spec Project in Pharm Pract (PMPR 35855), 1/12/2026 – 5/1/2026
Sexually Transmitted Infections (PHAR506), 4/21/2025 – Present
Sexually Transmitted Infections (PHAR506), 4/21/2025 – Present
Sexually Transmitted Infections (PHAR506), 4/17/2025 – Present
Nucleoside and Non-Nucleoside Reverse Transcriptase Inhibitors (PHAR506), 4/9/2025 – Present
Introduction to HIV and Opportunistic Infections (PHAR506), 4/7/2025 – Present
Opportunistic Infections Recitation (PHAR506), 4/7/2025 – Present
HIV and Interprofessional Education and Practice (HIPEP) (PMPR390), 1/28/2025 – 4/8/2025
Management of the HIV Patient: HIV and Aging (PMPR385), 10/22/2024 – Present
Selected Grants
AIDS Education and Training Centers, US Department of Health & Human Services (Health Resources and Services Administration)., 9/1/2022 - 8/31/2027, Obligated Amount: $2444024; Anticipated Amount: $3005342
Midwest Integration of the National HIV Curriculum, US Department of health and human services (Health Resources and Ser., 1/9/2022 - 8/31/2023, Obligated Amount: $600000; No Anticipated Amount Set
Testing Novel Pharmacogenetic and Adherence Optimization Treatments to Improve the Effectiveness of Smoking Cessation Treatments for Smokers with HIV, National Cancer Institute., 2019 - 2025, Obligated Amount: $15000; No Anticipated Amount Set
Integrating the National HIV Curriculum e-Learning Platform into Health Care Provider Professional Education, US Department of Health & Human Services (Health Resources and Services Administration)., 9/1/2018 - 8/31/2022, Obligated Amount: $2282453.14; Anticipated Amount: $2400000
Testing novel pharmacogenetic and adherence optimization treatments to improve the effectiveness of smoking cessation treatments for smokers with HIV, National Institute of Cancer., 9/1/2018 - Present, Obligated Amount: $1000000; No Anticipated Amount Set
Selected Publications
Wagner, Cornelia, Rivero, Ricardo, Stacks, Jonathan, Pierre, Natacha, Max, Blake. (2026). P-1890. Building the HIV Workforce through Integrating the National HIV Curriculum into Health Professions Programs in the United States. Open Forum Infectious Diseases, 13, (Supplement_1), ofaf695.2059. doi:10.1093/ofid/ofaf695.2059.
Kazanji, Noora, Max, Blake, Burgos, Rodrigo, Pham, Jennifer, Ford, Catherine. (2025). Third-Trimester HIV Viremia Treated with Long-Acting Cabotegravir and Rilpivirine: A Case Report. Open Forum Infectious Diseases, 12, (10), 1-4. doi:10.1093/ofid/ofaf604.
Kazanji, Noora, Max, Blake, Burgos, Rodrigo M, Pham, Jennifer T, Ford, Catherine E. (2025). Third-Trimester HIV Viremia Treated With Long-Acting Cabotegravir and Rilpivirine: A Case Report. Open Forum Infectious Diseases, 12, (10), ofaf604. doi:10.1093/ofid/ofaf604.
Luc, Casey Morgan, Max, Blake, Pérez, Sarah, Herrera, Kara, Huhn, Gregory, Dworkin, Mark S. (2024). Acceptability of Long-Acting Cabotegravir + Rilpivirine in a Large, Urban, Ambulatory HIV Clinic. JAIDS Journal of Acquired Immune Deficiency Syndromes, 97, (4), 409-415. doi:10.1097/qai.0000000000003500.
Max, Blake, DeMarais, Patricia. (2021). Elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide discontinuation and return to normal weight. International Journal of STD & AIDS, 32, (1), 92-95. doi:10.1177/0956462420964341.
Rock, Alex E, DeMarais, Patricia L, Vergara-Rodriguez, Pamala T, Max, Blake E. (2020). HIV-1 Virologic Rebound Due to Coadministration of Divalent Cations and Bictegravir. Infectious Diseases and Therapy, 9, (3), 691-696. doi:10.1007/s40121-020-00307-4.
Max, Blake. (2020). I’m not that good with taking pills everyday. What Do I Do Now? – Infectious Diseases. Oxford University Press.
Max, Blake. (2019). Update on HIV integrase inhibitors for the treatment of HIV-1 infection. Future Virology, 14, (10), 693-709. doi:10.2217/fvl-2019-0077.
Max, Blake, Stevens, B. (2018). Test and Treat: A new model for better patient outcomes. HIV Specialist.
Professional Leadership
Student Admissions Committee, University of Illinois at Chicago, 7/1/2024 - Present
American Academy of HIV Medicine, AAHIVM, 3/8/2022 - Present
ADAP Medical Advisory Board, Illinois Department of Public Health, 1/3/2022 - Present
Medical Advisory Board, 2021 - Present
Exam review and question writing, 2021 - Present
American Academy of HIV Medicine (AAHIV) Credentialing Exam Writer, 1/2019 - Present
MATEC Pharmacy Coordinator for Continuing Education, 1/2005 - Present
Education
Degrees:
PharmD, University of California, San Francisco, United States, 1994
Postgraduate Training:
Specialty Residency Infectious Diseases, University of Illinois at Chicago, United States, 1996
PGY-1, University of Illinois at Chicago, United States, 1995
Licensures and Certifications
AAHIVP, American Academy of HIV Medicine, Date Not Set - Present